Search Results - kenneth+witwer

2 Results Sort By:
Engineered Extracellular Vehicles as a selective drug delivery platform
Value Proposition:·      Engineered extracellular vesicles with enhanced uptake and reduced immunogenicity ·      Improved EV-based drug delivery platform  Technology DescriptionResearchers at Johns Hopkins have identified endogenous proteins that can be engineered to assist in extracellular vesicle and/or nanoparticle therapeutics through increased...
Published: 5/10/2024   |   Inventor(s): Kenneth Witwer, Zach Troyer
Keywords(s):  
Category(s): Clinical and Disease Specializations > Immuno-Oncology, Clinical and Disease Specializations > Infectious Diseases, Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Respiratory Diseases, Clinical and Disease Specializations > Rare Diseases, Clinical and Disease Specializations > Genetic Diseases, Technology Classifications > Therapeutic Modalities, Technology Classifications > Diagnostics
Culture-derived EVs for targeted delivery and treatment of B cell diseases
Value Proposition·      Purified EVs with preferential targeting for B cells in both ex-vivo and in-vivo applications.·      EVs have half-life between 30-40 minutes, longer than many comparable extracellular vesicles.·      EVs purified from cell culture medium to increase throughput, speed, and development of B-cell targeted therapies. Technology...
Published: 5/10/2024   |   Inventor(s): Kenneth Witwer, Tom Driedonks, Erin Shirk, Linglei Jiang
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum